PPT Slide
DepoMorphine: proprietary product
- 48 hours of pain relief with a single pre-op injection
- Convenient
- Better pain control from epidural administration (95% anaesthesiologists)
- Avoids problems from in-dwelling catheters
- Substantial pharmacoeconomic benefits
- Market size estimates: $350 million
- Phase III trial commenced in Q4 2000
- Enrolling 750+ patients
- Completion anticipated in 2002